Keywords: nanocarrer, nc-6004, ind, accepted, mhra, japanese, bio-venture

NanoCarrer's NC-6004 IND accepted by MHRA

Article | 06 February 2006

Print This

NanoCarrer, a Japanese bio-venture firm based in Kashiwa, Chiba, says that an Investigational New Drug application for its anticancer drug ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in